Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-21-064722
Filing Date
2021-12-10
Accepted
2021-12-10 16:30:28
Documents
1
Period of Report
2021-12-08

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 5126
  Complete submission text file 0001213900-21-064722.txt   6545
Mailing Address 830 MENLO AVENUE, SUITE 100 MENLO PARK CA 94025
Business Address 830 MENLO AVENUE, SUITE 100 MENLO PARK CA 94025 650-507-0669
180 Life Sciences Corp. (Issuer) CIK: 0001690080 (see all company filings)

EIN.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 501 BEALE STREET UNIT 8D SAN FRANCISCO CA 94105
Business Address
Rothbard Jonathan B. (Reporting) CIK: 0001833968 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38105 | Film No.: 211485745